- Home
- FTRE vs JELD Comparison
FTRE vs JELD Comparison
Compare FTRE & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- JELD
- Stock Information
- Founded
- FTRE 1996
- JELD 1960
- Country
- FTRE United States
- JELD United States
- Employees
- FTRE N/A
- JELD N/A
- Industry
- FTRE Medical Specialities
- JELD Forest Products
- Sector
- FTRE Health Care
- JELD Basic Materials
- Exchange
- FTRE Nasdaq
- JELD Nasdaq
- Market Cap
- FTRE 468.1M
- JELD 383.8M
- IPO Year
- FTRE N/A
- JELD 2017
- Fundamental
- Price
- FTRE $6.80
- JELD $5.17
- Analyst Decision
- FTRE Hold
- JELD Hold
- Analyst Count
- FTRE 11
- JELD 8
- Target Price
- FTRE $16.00
- JELD $7.34
- AVG Volume (30 Days)
- FTRE 2.5M
- JELD 1.5M
- Earning Date
- FTRE 08-06-2025
- JELD 08-05-2025
- Dividend Yield
- FTRE N/A
- JELD N/A
- EPS Growth
- FTRE N/A
- JELD N/A
- EPS
- FTRE N/A
- JELD N/A
- Revenue
- FTRE $2,685,600,000.00
- JELD $3,592,472,000.00
- Revenue This Year
- FTRE N/A
- JELD N/A
- Revenue Next Year
- FTRE $0.93
- JELD $3.40
- P/E Ratio
- FTRE N/A
- JELD N/A
- Revenue Growth
- FTRE N/A
- JELD N/A
- 52 Week Low
- FTRE $3.97
- JELD $3.27
- 52 Week High
- FTRE $27.99
- JELD $17.70
- Technical
- Relative Strength Index (RSI)
- FTRE 69.65
- JELD 68.58
- Support Level
- FTRE $4.46
- JELD $4.93
- Resistance Level
- FTRE $6.85
- JELD $5.17
- Average True Range (ATR)
- FTRE 0.47
- JELD 0.25
- MACD
- FTRE 0.21
- JELD 0.08
- Stochastic Oscillator
- FTRE 97.96
- JELD 96.88
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.